Member Info for Shukan

and our 50K seller at the keyboard !!

MJ the spread killed it

Indeed - BUY AND HOLD - those clowns selling before the big one LOL

Tick up tomorrow- one day closer to that Pharma Deal Buy and hold

We are off 15% up 3.45 paid

Tight ship - however they state a Global Player - my take is look at Lake Pharma they manufacture the CDX antibodies for Hemogenyx it’s all about connections

No LISTEN TO Dr Vlad interview - the play is not the trials that’s a year away - the play here is the LARGE CORPORATE LICENSING DEAL ON CDX -ANTIBODIES -“VERY SOON “HE SAID AFTER A CORRECTION FROM “SOON”

I had another chunk at 3p - good news awaits us

added again- any time now as we come to close Q2

£15 LOL- seriously!

5-6 pence range if momentum continues and the Pharma licence meets expectations as Vlad suggest it could well do for Hemogenyx validation of CDX it’s about to become interesting indeed

https://zakmir.com/2019/05/31/exclusive-interview-dr-vladislav-sandler-ceo-hemogenyx-pharma-hemo/

Strong buying

will take £15K 2.71p early on today I could not get a quote passed £2500

YES £20K @ 2.99

they will take £3K 2.675

We shall see

LakePharma, the largest US-based biologics contract research organization

In May 2018 the Company announced a Development Agreement ("Agreement") with a global biopharmaceutical company for the development of the Company's CDX antibodies. The Company is pleased to report that the development of CDX antibodies under the Agreement is progressing well, and the Company has initiated preliminary discussions with the partner regarding a potential licensing deal. Under the Agreement, Hemogenyx will receive on a cost-free basis technical support; access to advanced methods of discovering, developing and engineering antibodies; and certain intellectual property which is expected to assist the successful preclinical development of the Company's lead candidate bi-specific CDX antibodies. This will complement the Company's own development work currently being undertaken. Also, Hemogenyx will grant the global pharmaceutical company a research licence for anything jointly developed under the Agreement, as well as an option for an exclusive worldwide licence to commercially exploit CDX antibodies or any variants which will be jointly developed. If such option is not exercised by the global pharmaceutical company, the Company has the option to license the jointly developed CDX antibodies or any variants. Hemogenyx is already benefitting from the Agreement as its partner has produced good bi-specific antibodies which appear to be clinical grade, and further discussions will clarify their intentions. The Directors believe that either way Hemogenyx will benefit.

https://lakepharma.com/ And what do they do? They manufacture the CDX Antibodies Hemogenyx Pharma Plc - LakePharma appointed for lead product development @HemoGenyx https://www.**********.co.uk/rns/announcement/bd0b50c2-82b8-4dae-91d7-3cc878914c77 The rest draw your own conclusions -